Case Comprehensive Cancer Center (Case CCC) Cancer Health Disparities SPORE Planning Grant
凯斯综合癌症中心 (Case CCC) 癌症健康差异 SPORE 规划补助金
基本信息
- 批准号:10469702
- 负责人:
- 金额:$ 39.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-18 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAfrican AmericanAgeAgingAmericanBehavioralBiologicalCancer BurdenCancer EtiologyCancer PatientCessation of lifeColonColonic AdenomaColonic NeoplasmsColorectal CancerComprehensive Cancer CenterDNA MethylationDataDevelopmentDiseaseEpigenetic ProcessEthnic groupEuropeanFosteringGeneticGoalsGrantIncidenceIndividualIndustrializationInflammatoryInfrastructureLesionLife StyleLinkMacrophage ActivationMalignant NeoplasmsMalignant neoplasm of prostateMediator of activation proteinMethodologyMolecularMorbidity - disease rateNeighborhoodsOutcomePathologyPatientsPopulationPopulation StudyProgram Research Project GrantsResearchResearch PersonnelResearch Project GrantsResourcesRiskRisk AssessmentRisk FactorsSeriesServicesSignal TransductionSpecialized Program of Research ExcellenceStructureSystems BiologyTechnologyTestingTissuesTranslational ResearchUnited StatesWorkZNF151 genebasecancer health disparitychemotherapycohortcontextual factorslifestyle factorsmacrophagemalignant breast neoplasmmolecular markermortalitynovelnovel strategiesprogramsracial differenceracial disparityresearch studyresponsesocioeconomicstranslational scientisttreatment responsetriple-negative invasive breast carcinomatumortumor-immune system interactions
项目摘要
Overall Summary/Abstract
The Case Cancer Disparities P20 proposal provides for planning and development of a Specialized Program of
Research Excellence (SPORE) in cancer health disparities. This proposal places an emphasis on colon
adenoma, precursor lesion of colorectal cancer (CRC), and on breast cancer, which are the two leading
causes of cancer death in the United States, and of which, racial disparities persist and are widening. This
proposed P20 program builds on the resources of the Case Comprehensive Cancer Center to propose two
cutting edge translational Research Projects that use multi-level risk assessment approaches for examining
racial difference and epigenetic aging in the development of early colon neoplasia (Project 1) and use systems
biology approaches for interrogating molecular mechanisms underlying racial disparities in triple negative
breast cancer (TNBC) response to treatment and survival (Project 2). These two Research Projects each are
built upon substantial preliminary data, cutting edge technology and methodology, and enabling patient cohorts
and tissues to test novel hypotheses with high translational significance. This P20 program will further develop
a comprehensive infrastructure for catalyzing a robust Developmental Research Program (DRP) that extend
our efforts to other cancers and socioeconomic, demographic and behavioral factors contributing to cancer
disparities. A series of 2 core resources support these projects and also establish a strong programmatic
infrastructure for transdisciplinary translational research in cancer health disparities. The proposal brings
together a highly transdisciplinary team of investigators that work collaboratively through every stages and
aims of the proposed research studies to accomplish the translational goal of this P20 application.
总体总结/摘要
案例癌症差异 P20 提案规定规划和制定一项专门计划
癌症健康差异方面的卓越研究 (SPORE)。该提案强调冒号
腺瘤、结直肠癌 (CRC) 的前驱病变和乳腺癌是两个主要的癌症
美国癌症死亡原因中,种族差异持续存在且正在扩大。这
拟议的 P20 计划以凯斯综合癌症中心的资源为基础,提出了两个
使用多层次风险评估方法进行检查的尖端转化研究项目
早期结肠肿瘤发展中的种族差异和表观遗传衰老(项目1)和使用系统
探究三阴性种族差异背后分子机制的生物学方法
乳腺癌 (TNBC) 对治疗和生存的反应(项目 2)。这两个研究项目分别是
建立在大量初步数据、尖端技术和方法的基础上,并支持患者群体
和组织来测试具有高度转化意义的新假设。这个P20计划将进一步发展
一个全面的基础设施,用于促进强大的发展研究计划(DRP),
我们对其他癌症以及导致癌症的社会经济、人口和行为因素所做的努力
差异。一系列 2 个核心资源支持这些项目,并建立了强大的计划性
癌症健康差异跨学科转化研究的基础设施。该提案带来
一个高度跨学科的研究团队聚集在一起,在每个阶段进行协作,
拟议研究的目的是实现该 P20 应用程序的转化目标。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Spatial analysis of colorectal cancer outcomes and socioeconomic factors in Virginia.
- DOI:10.1186/s12889-021-11875-6
- 发表时间:2021-10-21
- 期刊:
- 影响因子:4.5
- 作者:Thatcher EJ;Camacho F;Anderson RT;Li L;Cohn WF;DeGuzman PB;Porter KJ;Zoellner JM
- 通讯作者:Zoellner JM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nathan A. Berger其他文献
Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availability.
由于酶活性或底物可用性的稳定改变,突变细胞在聚(ADP-核糖)合成方面存在缺陷。
- DOI:
- 发表时间:
1989 - 期刊:
- 影响因子:3.7
- 作者:
S. Chatterjee;N. Hirschler;S. Petzold;S. J. Berger;Nathan A. Berger - 通讯作者:
Nathan A. Berger
Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell lines.
表鬼臼毒素诱导聚(二磷酸腺苷-核糖)合成缺陷的 V79 中国仓鼠细胞系细胞死亡的机制。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:11.2
- 作者:
S. Chatterjee;Divyang Trivedi;S. Petzold;Nathan A. Berger - 通讯作者:
Nathan A. Berger
Nathan A. Berger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nathan A. Berger', 18)}}的其他基金
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
远程医疗抵抗运动干预以保持老年乳腺癌患者的剂量强度和活力(THRIVE)
- 批准号:
10450916 - 财政年份:2022
- 资助金额:
$ 39.86万 - 项目类别:
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
远程医疗抵抗运动干预以保持老年乳腺癌患者的剂量强度和活力(THRIVE)
- 批准号:
10754983 - 财政年份:2022
- 资助金额:
$ 39.86万 - 项目类别:
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
远程医疗抵抗运动干预以保持老年乳腺癌患者的剂量强度和活力(THRIVE)
- 批准号:
10608200 - 财政年份:2022
- 资助金额:
$ 39.86万 - 项目类别:
Case Comprehensive Cancer Center (Case CCC) Cancer Health Disparities SPORE Planning Grant
凯斯综合癌症中心 (Case CCC) 癌症健康差异 SPORE 规划补助金
- 批准号:
10005904 - 财政年份:2018
- 资助金额:
$ 39.86万 - 项目类别:
Case CCC Youth Engaged in Science, 09/01/2022-08/31/2027
案例 CCC青年从事科学,09/01/2022-08/31/2027
- 批准号:
10686983 - 财政年份:2017
- 资助金额:
$ 39.86万 - 项目类别:
Case CCC Youth Engaged in Science, 09/01/2022-08/31/2027
案例 CCC青年从事科学,09/01/2022-08/31/2027
- 批准号:
10514949 - 财政年份:2017
- 资助金额:
$ 39.86万 - 项目类别:
相似海外基金
Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
- 批准号:
10658457 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别:
The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
人类SLE致病变异NCF1.pR90H在促进肾脏损伤中的作用
- 批准号:
10740630 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别:
Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety Testing
用于药物基因组学和药物安全性测试的种族多样化 iPSC-心肌细胞小组
- 批准号:
10755624 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别:
Common mechanistic biomarkers of vascular and neuro-degeneration
血管和神经变性的常见机制生物标志物
- 批准号:
10567120 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别:
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma
糖化与祖先特异性肿瘤基质之间的因果关系
- 批准号:
10586185 - 财政年份:2023
- 资助金额:
$ 39.86万 - 项目类别: